Maria C. Sergi

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.

Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: April 08, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Journal: Journal for immunotherapy of cancer

Published: March 31, 2026

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Journal: Frontiers in immunology

Published: November 03, 2025

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 08, 2025

Basal Cell Carcinoma: An Old Friend with Multiple Faces.

Basal Cell Carcinoma: An Old Friend with Multiple Faces.

Journal: Cancers

Published: January 12, 2025

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 02, 2023

Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.

Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.

Journal: Current oncology reports

Published: August 21, 2023

Delayed cold-type autoimmune hemolytic anemia responding to Rituximab in a melanoma patient treated with Ipilimumab and Nivolumab.

Delayed cold-type autoimmune hemolytic anemia responding to Rituximab in a melanoma patient treated with Ipilimumab and Nivolumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 20, 2023

Checkpoint Inhibitor-Induced Colitis: An Update.

Checkpoint Inhibitor-Induced Colitis: An Update.

Journal: Biomedicines

Published: March 28, 2023

An update on Merkel cell carcinoma.

An update on Merkel cell carcinoma.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: January 27, 2023

Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.

Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.

Journal: Cancers

Published: December 19, 2022

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Journal: Journal of the National Cancer Institute

Published: November 08, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026